These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 95055)

  • 41. A comparative study on short course chemotherapy in sputum negative pulmonary tuberculosis.
    Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1984 Aug; 67(8):429-31. PubMed ID: 6084041
    [No Abstract]   [Full Text] [Related]  

  • 42. Thiacetazone in pulmonary tuberculosis with reference to its clinical intolerance.
    Sen PK; Sen NN; Saha JR; Paul NB; Prodhan PK
    Indian J Med Res; 1970 Aug; 58(8):1002-11. PubMed ID: 4099710
    [No Abstract]   [Full Text] [Related]  

  • 43. A second international co-operative investigation into thiacetazone side-effects. Rashes on two thiacetazone containing regimens.
    Ferguson GC; Nunn AJ; Fox W; Miller AB; Robinson DK; Tall R
    Tubercle; 1971 Sep; 52(3):166-81. PubMed ID: 4106401
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative trials of 3 ambulatory therapeutic methods for pulmonary tuberculosis in Senegal. (Preliminary results of TB1)].
    Rabier M; Sarrat H
    Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):751-62. PubMed ID: 4114357
    [No Abstract]   [Full Text] [Related]  

  • 45. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
    Smith TC; Richardus JH
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):353-8. PubMed ID: 7525795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactions to thiacetazone.
    Sarma OA
    Indian J Chest Dis Allied Sci; 1976 Jan; 18(1):51-5. PubMed ID: 57922
    [No Abstract]   [Full Text] [Related]  

  • 47. Toxic epidermal necrolysis as a result of anti-tubercular drugs.
    Sehgal VN; Bahadur P; Ghosh SK; Vadiraj SN
    Indian J Chest Dis; 1973 Jan; 15(1):57-60. PubMed ID: 4121136
    [No Abstract]   [Full Text] [Related]  

  • 48. A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore. Singapore Tuberculosis Services-Brompton Hospital-British Medical Research Council Investigation.
    Tubercle; 1971 Jun; 52(2):88-116. PubMed ID: 4104642
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of pulmonary tuberculosis by combining isoniazide and thiacetazone in the Province of Marrakech (Morocco)].
    Durante C; Burzoni FJ
    Rev Tuberc Pneumol (Paris); 1968; 32(6):849-59. PubMed ID: 4194278
    [No Abstract]   [Full Text] [Related]  

  • 50. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiacetazone reactions.
    Munthali MM; Warndoff DK; Koka CW; Glynn JR; Salaniponi FL
    Trans R Soc Trop Med Hyg; 1995; 89(2):238. PubMed ID: 7539955
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
    Kundu SK; Ghosh S; Hazra S; Chaudhury S
    Lepr India; 1981 Apr; 53(2):248-58. PubMed ID: 6166791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies.
    Kelly P; Buve A; Foster SD; McKenna M; Donnelly M; Sipatunyana G
    Trans R Soc Trop Med Hyg; 1994; 88(1):113-5. PubMed ID: 7512287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiacetazone and INH in tuberculosis. Synchronised peak concentration drug administration for greater action.
    Sen PK; Chatterjee R; Saha JR
    J Indian Med Assoc; 1973 Oct; 61(7):306-8. PubMed ID: 4129969
    [No Abstract]   [Full Text] [Related]  

  • 55. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone.
    Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055
    [No Abstract]   [Full Text] [Related]  

  • 57. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 58. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koula-Shiro S
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thiacetazone-isoniazid combination in the treatment of pulmonary tuberculosus.
    Mital OP; Ramalingam JT; Agarwala MC
    J Indian Med Assoc; 1968 May; 50(10):468-73. PubMed ID: 4178704
    [No Abstract]   [Full Text] [Related]  

  • 60. Cutaneous sensitivity to thiacetazone.
    Fegan D; Glennon J
    Lancet; 1991 Apr; 337(8748):1036. PubMed ID: 1708068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.